HOME >> BIOLOGY >> NEWS
GroPep infertility data presented at US meeting

GroPep's program to develop a treatment for infertility reached another milestone with the release of key data at the 25th Anniversary Meeting of the American Society for Reproductive Immunology in the US. The data will be presented by a leading international researcher in infertility.

More than 50% of recurrent miscarriages have no apparent explanation* and the market for a drug to correct this is potentially worth up to US$750 million annually.

Following the success of pre-clinical studies performed at McMaster University in Canada, the GroPep drug is on track to be tested in Phase I trials during 2006.

A leading international infertility researcher, Professor David Clark, will present key pre-clinical data on GroPep's infertility drug, PV903, at the 25th Anniversary Meeting of the American Society for Reproductive Immunology in Providence, Rhode Island, 16-18 June 2005.

Professor Clark's research found that administration of a single dose of the GroPep drug PV903 halved the miscarriage rate in a strain of female mice susceptible to the immune rejection of the foetus (a suspected major cause of recurrent miscarriage in women).

Scientists believe that women who suffer from repeated miscarriage have an immune system that attacks the embryo as "foreign" in the same way it would a virus or bacteria. The GroPep drug contains an active ingredient found in semen (called a "cytokine") that is thought to instruct the mother's immune system to "tolerate" the foetus.

Professor Clark, who was President of the American Society for Reproductive Immunology between 1996 and 1998, said: "This is the first time a cytokine has been shown to positively affect reproductive outcome in an animal model of reproductive failure that shares many pathological features with recurrent miscarriage in humans. Clinical trials in women with a history of recurrent miscarriage are warranted."

He further noted that: "Past advances in endo
'"/>

Contact: Mr Tony Mitchell
investorrelations@gropep.com.au
61-8-8354-7700
Research Australia
13-Jun-2005


Page: 1 2

Related biology news :

1. GroPep announces US FDA approval of biopharmaceutical that uses its cell culture product
2. GroPep announces Japanese approval of biopharmaceutical that uses its cell culture products
3. Male or female factor infertility -- men suffer just the same
4. Risk-taking in infertility treatment correlates with womens negative moods
5. New research holds promise for protecting cancer patients against infertility
6. Stressed-out African naked mole-rats may provide clues about human infertility
7. Key to male infertility
8. Researchers find gene mutation that causes infertility in male mice
9. Treating male infertility with stem cells
10. Eating ice cream may help women to conceive, but low-fat dairy foods may increase infertility risk
11. World-first stem cell research could aid male infertility

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2020)... ... June 25, 2020 , ... In an upcoming episode scheduled for the fall ... Care Testing solutions (POCT). Check local listings for more info. , Today, the majority ... are shipped to labs throughout the country. Results are then available several days later. ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... healthcare, and Renovagen Ltd, a UK supplier and manufacturer of innovative portable renewable ... testing operations in the fight against the COVID-19 pandemic in Zambia. , One ...
(Date:6/23/2020)... ... June 23, 2020 , ... In its June 22 ... with Dr. James L. Sherley, M.D., Ph.D., founder and director of stem cell ... announced on June 16 that starting July 5 it would begin offering ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... ... solutions to aid in the early detection and prevention of high-burden diseases, and ... enable US-based hospitals and healthcare organizations to utilize existing data in order to ...
(Date:7/10/2020)... ... 2020 , ... In most research using the zebrafish model, ... in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. Over the past ... the zebrafish model to investigate the causes of leukaemia and its relationship with ...
(Date:7/1/2020)... ... June 29, 2020 , ... MedShift , ... in 2020, despite many obstacles created as a result of COVID-19. As a ... its partnered medical practices and medical manufacturers by expanding access to device offerings, ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... develop a vaccine or drug treatment. In an effort to better understand the ... released the world’s largest imaging dataset portraying therapeutic compound effects from over 1,600 ...
Breaking Biology Technology:
Cached News: